Clinical Trial

The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

Study acronym: rUTI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2022 (before its estimated August 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
Investigate the effect of dietary supplements/probiotic ASTARTE™ ( L. crispatus, L. rhamnosus, L. jensenii, L. gasseri) on the microbiome composition in the intestine and vagina and thereby a reduction of risk factors for the development of rUTI during 6 months of intervention in women aged 18-40 years. This is measured by the incidence of symptomatic UTI.
Trial Details
NCT Number NCT05553652
Lead Sponsor Hvidovre University Hospital
Conditions Recurrent Urinary Tract Infection
Enrollment 720 participants
Start Date 2022-09-19
Primary Completion 2024-08-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2022-09-23